These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32301604)

  • 1. In Vitro Phase I Metabolic Profiling of the Synthetic Cannabinoids AM-694, 5F-NNEI, FUB-APINACA, MFUBINAC, and AMB-FUBINACA.
    Apirakkan O; Gavrilović I; Cowan DA; Abbate V
    Chem Res Toxicol; 2020 Jul; 33(7):1653-1664. PubMed ID: 32301604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry.
    Andersson M; Diao X; Wohlfarth A; Scheidweiler KB; Huestis MA
    Rapid Commun Mass Spectrom; 2016 Apr; 30(8):1067-78. PubMed ID: 27003044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.
    Fabregat-Safont D; Mardal M; Noble C; Cannaert A; Stove CP; Sancho JV; Linnet K; Hernández F; Ibáñez M
    Drug Test Anal; 2019 Sep; 11(9):1358-1368. PubMed ID: 31192526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
    Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
    Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic characteristic profiling of 1-amino-3,3-dimethyl-1-oxobutan-2-yl-derived indole and indazole synthetic cannabinoids in vitro.
    Luo X; Huang Z; Huang K; Liu X; Yang N; Luo Q
    J Pharm Biomed Anal; 2024 Nov; 250():116385. PubMed ID: 39116582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic profiling of synthetic cannabinoid 5F-ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra-high-performance liquid chromatography/high-resolution mass spectrometry.
    Presley BC; Castaneto MS; Logan BK; Jansen-Varnum SA
    Rapid Commun Mass Spectrom; 2020 Nov; 34(22):e8908. PubMed ID: 32710798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
    Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
    Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of synthetic cannabinoid FUB-AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC-MS/MS.
    Presley BC; Castaneto MS; Logan BK; Jansen-Varnum SA
    Biomed Chromatogr; 2020 Sep; 34(9):e4884. PubMed ID: 32415732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation.
    Gaunitz F; Thomas A; Fietzke M; Franz F; Auwärter V; Thevis M; Mercer-Chalmers-Bender K
    Int J Legal Med; 2019 Jul; 133(4):1049-1064. PubMed ID: 30564916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol.
    Wang Z; Fong CY; Goh EML; Moy HY; Chan ECY
    J Anal Toxicol; 2023 Jan; 46(9):1016-1024. PubMed ID: 34918103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
    Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
    Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.
    Li J; Liu C; Li T; Hua Z
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 28992356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems.
    Gampfer TM; Wagmann L; Belkacemi A; Flockerzi V; Meyer MR
    Arch Toxicol; 2021 Nov; 95(11):3539-3557. PubMed ID: 34453555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
    Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
    ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of AMB-FUBINACA Biotransformation Pathways in Human Liver Microsome and Zebrafish Systems by Liquid Chromatography-High Resolution Mass Spectrometry.
    Xu DQ; Zhang WF; Li J; Wang JF; Qin SY; Lu JH
    Front Chem; 2019; 7():240. PubMed ID: 31041306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.